Study design for 1-MT testing in hu-PBL-NOD/SCID HIVE mice
. | Week of killing, n . | . | . | ||
|---|---|---|---|---|---|
| Treatment group . | Week 1 . | Week 2 . | Week 3 . | ||
| Control | 7 | 17 (7)* | 8 (6) | ||
| 1-MT | 8 | 17 (7) | 15 (8) | ||
. | Week of killing, n . | . | . | ||
|---|---|---|---|---|---|
| Treatment group . | Week 1 . | Week 2 . | Week 3 . | ||
| Control | 7 | 17 (7)* | 8 (6) | ||
| 1-MT | 8 | 17 (7) | 15 (8) | ||
Three independent experiments were performed.
The number of mice in the third experiment is shown in parentheses